Company intelligence / Profile preview
Treatwell Pharma
- Ownership
- Private
- Development stage
- Other
Overview
Treatwell Pharma is a commercial-stage, ISO 9001:2015 certified GMP pharmaceutical manufacturer offering a broad range of generic and branded medicines, including antibiotics, anti-inflammatory agents, antiulcer drugs, antiallergics, neuropsychiatric, gynecology, and other therapeutic categories, with ongoing global and Indian market distribution.
- Therapeutic areas
- ImmunologyRheumatologyMetabolic DisordersInfectious DiseasesPulmonology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Treatwell Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Treatwell Pharma.